Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Prellis Biologics Receives $8.7M, Reports Tissue Printing Progress

Facebook Twitter LinkedIn Email Comments
Prellis Biologics, developer of a holographic organ printing system, has received an $8.7 million investment led by Khosla Ventures. The investment is a Series A and comes after Prellis announced major milestones in tissue engineering.


Prellis structure transplanted alone is surrounded by single cell walled capillaries within two weeks of transplantation into immunocompetent mouse (left). Human tumor cells transplanted in Prellis structures grow rapidly, are highly vascularized, and demonstrate minimal hypoxia (right) (red = CD31, blue = DAPI, green = printed structure). Courtesy of Prellis Biologics.



The company recently reported positive results from the first animal transplantation of its 3D tissue scaffolds — called Vascular Tissue Blanks — carried out at Stanford University. The transplanted structures were found to support human tumor growth rate at rates that are similar or better than typical tumor transplant methods, and with fewer cells. Typical tumor studies in animals require 2 million or more cells. With Prellis’ technology, full tumor engraftment and vascularization were achieved with just 200,000 cells, said Prellis co-founder and CEO Melanie Matheu.

“A breakthrough like this opens the door to studying rare human tumors and complex human tumor immune system reactions,” Matheu said. “It has the potential to significantly reduce overall animal use and speed up drug discovery efforts.”

Currently, more than 30 pharmaceutical and academic research labs, including groups at UC San Francisco, Johns Hopkins, UC Irvine, and Memorial Sloan Kettering, are experimenting with the technology.

The company’s original seed round investors include True Ventures and Indie Bio, and have joined Khosla in the round. Total invested capital in Prellis is currently at $10.5 million.

BioPhotonics
Sep 2019
GLOSSARY
holography
The optical recording of the object wave formed by the resulting interference pattern of two mutually coherent component light beams. In the holographic process, a coherent beam first is split into two component beams, one of which irradiates the object, the second of which irradiates a recording medium. The diffraction or scattering of the first wave by the object forms the object wave that proceeds to and interferes with the second coherent beam, or reference wave at the medium. The resulting...
BiophotonicsResearch & Technologytissue engineeringInvestmentsPrellis Biologicsholography3d printingRapidScan

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.